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Summary 
COVID-19 is caused by SARS-CoV-2 infection and was first reported in central China in December 
2019([WHQVLYHPROHFXODUVXUYHLOODQFHLQ*XDQJGRQJ&KLQD¶VPRVWSRSXORXVSURYLQFHduring early 
2020 resulted in 1,388 reported RNA-positive cases from 1.6 million tests. In order to understand the 
molecular epidemiology and genetic diversity of SARS-CoV-2 in China we generated 53 genomes 
from infected individuals in Guangdong using a combination of metagenomic sequencing and tiling 
amplicon approaches. Combined epidemiological and phylogenetic analyses indicate multiple 
independent introductions to Guangdong, although phylogenetic clustering is uncertain due to low 
virus genetic variation early in the pandemic. Our results illustrate how the timing, size and duration 
of putative local transmission chains were constrained by national travel restrictions and by the 
SURYLQFH¶Vlarge-scale intensive surveillance and intervention measures. Despite these successes, 
COVID-19 surveillance in Guangdong is still required as the number of cases imported from other 
countries has increased.  
Introduction 
A new virus-associated disease, COVID-19 (coronavirus disease 2019), was initially reported in 
China on 30th December 2019 (Wu et al., 2020). The causative agent of COVID-19 is the novel 
human coronavirus SARS-CoV-2 (Wu et al., 2020; Zhou et al., 2020) and, as of 24th March 2020, 
there have been 372,757 confirmed infections and 16,231 deaths reported worldwide (WHO, 2020). 
In China, the COVID-19 epidemic grew exponentially during January 2020, peaking on 12th February 
2020 with 15,153 newly confirmed cases per day. One month later, reported COVID-19 cases in 
China dropped to approximately 20 per day, indicating the epidemic there was contained. However, 
the number of cases reported outside of China has risen exponentially since the second half of 
February 2020. By 11th March 2020, the day that WHO announced COVID-19 to be a new pandemic, 
37,371 cases had been reported outside of China (WHO, 2020). 
Guangdong Province and the Pearl River Delta Metropolitan Region contain some RIWKHZRUOG¶V
largest and most densely populated urban areas. Guangdong is the most populous province of China 
(113m people) and contains many large cities including Guangzhou (12m), Shenzhen (10m), 
Dongguan (8m), and Foshan (7m). The province has strong transportation links to Hubei Province, 
where the first cases of COVID-19 were reported. The Wuhan±Guangzhou high-speed railway has 
been estimated to transfer 0.1±0.2 million passengers per day during the spring festival period, which 
started on 10th January 2020. By 19th March 2020, Guangdong had 1,388 confirmed cases of COVID-
19, the highest in China outside of Hubei Province.  
Understanding the evolution and transmission patterns of a virus after it enters a new population is 
crucial for designing effective strategies for disease control and prevention (Faria et al. 2018; 
Grubaugh et al., 2017; Ladner et al., 2019). In this study, we combine genetic and epidemiological 
data to investigate the genetic diversity, evolution, and epidemiology of SARS-CoV-2 in Guangdong 
Province. We generated virus genome sequences from 53 patients in Guangdong using both 
metagenomic sequencing and multiplex PCR amplification followed by nanopore sequencing. 
Through phylogenetic analysis, interpreted in the context of available epidemiological information, 
we sought to investigate the timing and relative contributions of imported cases versus local 
transmission, the nature of genetically-distinct transmission chains within Guangdong, and how the 
emergency response in Guangdong was reflected in the reduction and elimination of these 
transmission chains. Our results may provide valuable information for implementing and interpreting 
genomic surveillance of COVID-19 in other regions. 
Results 
Enhanced surveillance was launched in all clinics in Guangdong province following the first reports 
of patients with undiagnosed pneumonia on 30th December 2019. Initially, screening and sampling for 
SARS-CoV-2 was targeted towards patients with fever and respiratory symptoms and those who had a 
history of travel in the 14 days before the date of symptom onset. The first detected case in 
Guangdong had symptom onset on 1st January and was reported on 19th January 2020 (Kang et al. 
2020). COVID-19 cases in Guangdong grew until early February 2020 (peaking at >100 cases per 
day) and declined thereafter (Figure 1A). After 22nd February 2020, the daily number of locally-
infected reported cases in Guangdong did not exceed one. However, since the beginning of March 
2020 COVID-19 cases imported into Guangdong from abroad have been detected with increasing 
frequency. As of 26th March 2020, a total of 102 imported cases were reported from 19 different 
countries (Figure 1A), highlighting the risk that local COVID-19 transmission could reignite in China. 
Different surveillance strategies were applied during the epidemic in Guangdong (Figure 1A; 
Methods). More intense surveillance was initiated on 30th January 2020 in response to the Spring 
Festival period, which results in greater mobility among regions and provinces in China (Kraemer et 
al., 2020; Tian et al. 2020) and because asymptomatic COVID-19 cases had been reported (Guan et 
al., 2020). This included monitoring (i) all travelers returning from Hubei or other regions with high 
epidemic activity, (ii) their close contacts, and (iii) all hospitalized patients in clinics, including those 
without fever or respiratory symptoms, regardless of their exposure history. Approximately 1.35 
million samples were screened by six third-party institutions between 30th January and 15th March 
2020. Surveillance commenced at Guangdong airports in early March, following the growth of 
COVID-19 outbreaks outside of China. In total, approximately 1.6 million tests were performed by 
19th March, identifying 1,388 SARS-CoV-2 positive cases in 20 of 21 prefectures in Guangdong 
Province (Figure 1B). Around a quarter of cases (336) were judged to be linked to local transmission 
and two-thirds (1014) had a likely exposure history in Hubei (see Methods). For locally-infected 
cases, 181 (53%) were linked to transmission among household members. More than half of the 
reported cases (60%) were from the cities of Shenzhen and Guangzhou (Figure 1B). We note that the 
number of detected cases will be less than the true number of infections, although the degree of under-
reporting is unknown. Surveillance was targeted towards travellers, hence these data may 
overestimate the proportion of travel-associated cases.  
To understand the genetic structure of the COVID-19 outbreak in Guangdong, we generated near-
complete and partial genomes from 53 COVID-19 patients in Guangdong Province. The genomes 
were generated by a combination of metagenomic sequencing and multiplex PCR amplification 
followed by nanopore sequencing on a MinION device (see Methods). Sequence sampling dates 
ranged from 30th January to 28th February 2020 (Figure S1). 
Sequencing was performed on 79 clinical samples (throat swabs n=32, anal swabs n=24, 
nasopharyngeal swabs n=10, sputum n=13) collected from 62 patients with varying disease 
symptoms, ranging from asymptomatic to very severe (see Methods). RT-PCR Ct (cycle threshold) 
values of these samples ranged from 19 to 40.86. Figure 2A displays the Ct values for the 53 samples 
with >50% genome coverage for which we report whole and partial genome sequences (see Figure S2 
for details of all 79 samples). When Ct values are <30, sequence reads covered approximately 90% or 
more of the reference genome (GenBank accession number: MN908947.3) irrespective of the 
amplification and sequencing approach used (see Methods). However, genome coverage declined for 
samples with Ct >30 (Figure S2). Using a Kruskal-Wallis rank sum test we found an association 
between sample Ct values and sample type (Figure 2B; p<0.001), and sample Ct values and disease 
severity (Figure 2C; p=0.03; see also Liu et al. 2020), however we note that sampling was not 
undertaken with these hypotheses in mind.  
Sequences generated with nanopore sequencing indicate common regions of low coverage (Figure 
2D), indicating that the version 1  primer set used here did not amplify some regions 
efficiently. Efficient primer binding may have been prevented due to genetic divergence from the 
reference genome (MN908947.3). An alternative explanation is the interaction between two 
particular primers, resulting in primer dimer formation (Itokawa et al. 2020). After completion of 
this study, the primers have been redesigned to address these issues and improve coverage (Quick 
2020). Shared and unique single nucleotide polymorphisms (SNPs) were observed at 97 sites across 
the SARS-CoV-2 genome (Figure 2D, 2E), with 77 SNPs present in only one genome. Three SNPs 
were present in >10 genomes: (C8782T, C21711T and T28144C). When compared to 49 previously 
released genomes from Hubei and Guangdong, 118 SNPs are present in only one genome and these 
three SNPs are still the only variants shared among >10 genomes (Supplemental Data File). 
To understand the genetic diversity of the SARS-CoV-2 epidemic in Guangdong we performed 
phylogenetic analyses using maximum likelihood and Bayesian molecular clock approaches. We 
added our new virus genomes from Guangdong to 177 publicly-available sequences, which includes 
73 sequences from China, 17 of which were previously-reported Guangdong genomes. The final 
alignment comprised 250 sequences and increased the number of SARS-CoV-2 sequences from China 
by ~60% when our data was submitted to GISAID (on 9th March).  
The estimated maximum likelihood (ML) phylogeny is shown in Figure 3A. The SARS-CoV-2 
sequences from Guangdong (red) are interspersed with viral lineages sampled from other Chinese 
provinces and other countries (grey). This pattern agrees with the epidemiological time series in 
Figure 1A, indicating that most detected cases were linked to travel rather than local community 
transmission. Despite this, there were a number of instances where sequences from Guangdong 
appeared to cluster together, sometimes with sequences sampled from other regions. To explore these 
lineages in more detail, we performed a Bayesian molecular clock analysis that places the 
phylogenetic history of the genomes on an estimated timescale. A summary visualisation of the 
maximum clade credibility tree from that analysis is shown in Figure 3B and is largely congruent with 
the ML tree. The current low genetic diversity of SARS-CoV-2 genomes worldwide means that most 
internal nodes have very low posterior probabilities; we caution that no conclusions should be drawn 
from these branching events as they will be informed by the phylogenetic prior distribution rather 
than variable nucleotide sites (Figure 3A). Nevertheless, five clusters (denoted A-E) containing 
Guangdong sequences had posterior probability support of >80% (i.e. their sequences grouped 
monophyletically in >80% of trees in the posterior sample; Figure 3B). These clusters were also 
observed in ML phylogeny (Figure 3A). Some included only sequences sampled in Guangdong (A, 
B), others included sequences sampled in other countries and provinces (C, D, E).   
From the molecular clock analysis, we were able to estimate the times of the most recent common 
ancestor (tMRCA) of clusters A-E. We find that SARS-CoV-2 lineages were imported multiple times 
into Guangdong during the second half of January 2020 (Figure 4). Three clusters (C, D, E) have 
earlier tMRCAs that coincide with the start of the Guangdong epidemic and two (A, B) have later 
tMRCAs, around the time of the epidemic peak in the province (Figure 4).  The average time between 
the tMRCA and the earliest sequence collection date in each cluster was approximately 10.25 days. 
The observed duration of each phylogenetic cluster (tMRCA to most recently sampled sequence) 
ranged from 9.49 (cluster B) to 45.2 (cluster D) days. The clusters with earlier tMRCAs contain more 
sequences from travellers sampled outside of China, possibly reflecting a decrease in air passenger 
travel from Guangdong after January 2020 (Flightradar 2020). The median tMRCA estimate of the 
COVID-19 pandemic was 1st December 2019 (95% HPD 15th November to 13th December 2019; 
Figure 4), consistent with previous analyses (Rambaut 2020).  
The apparent clusters of Guangdong sequences require careful interpretation because of the relative 
undersampling of SARS-CoV-2 genomes from other Chinese provinces, including Hubei. 
Specifically, it is known that undersampling of regions with high incidence can lead to phylogenetic 
analyses underestimating the number of introductions into recipient locations, and overestimating the 
size and duration of transmission chains in those recipient locations (Grubaugh et al., 2017; Kraemer 
et al., 2018). For example, the largest Guangdong phylogenetic cluster (denoted A in Figures 3,4) 
comprises 8 sequences, none of which are placed at the root of the cluster, and it is tempting to 
conclude that the entire cluster derived from community transmission within Guangdong. However, 6 
of the 8 genomes reported travel from Hubei and therefore the cluster in fact represents multiple 
SARS-CoV-2 introductions into Guangdong, with dates of symptom onset around or shortly after the 
shutdown of travel from Wuhan (Figure 4). 
Discussion 
Our analyses of the genomic epidemiology of SARS-CoV-2 in Guangdong province indicate that, 
following the first COVID-19 case detected in early January, most infections were the result of virus 
importation from elsewhere, and that chains of local transmission were limited in size and duration. 
This suggests that the large-scale surveillance and intervention measures implemented in Guangdong 
were effective in interrupting community transmission in a densely populated urban region, ultimately 
containing the epidemic and limiting the potential for dissemination to other regions (Leung et al. 
2020). However, vigilance is still required as there remains a risk that SARS-CoV-2 transmission 
could reignite in Guangdong following the recent increase in the number of COVID-19 cases 
imported to China from other countries. 
The results also suggest that analyses of phylogenetic structure during the early phase of the pandemic 
should be interpreted carefully. The number of mutations that define phylogenetic lineages are small 
(often one), and may be similar to the number of sequence differences arising from errors introduced 
during reverse transcription, PCR amplification, or sequencing. Bayesian estimates of divergence 
times (Rannala and Yang, 1996), such as the tMRCA of the pandemic, are based on aggregate 
numbers of mutations and informed by dense sampling through time, and are thus expected to be 
more robust. Further, the low and variable sampling of COVID-19 cases among different regions 
makes it challenging to evaluate phylogenetic clusters that comprise cases from a single region; 
although such clusters could indeed represent local transmission, our results show they can also 
include multiple introductions from a genomically-undersampled location. Therefore, as with all 
phylogenetic analyses, the SARS-CoV-2 genomes must be interpreted in the context of all available 
epidemiological information.  
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Figure 1: Summary of the COVID-19 epidemic in Guangdong Province, China. (A) Time series 
of the 1,388 laboratory-confirmed COVID-19 cases in Guangdong until 19th March, by date of onset 
of illness. Cases are classified according to their likely exposure histories (see inset and main text). 
The dashed lines indicate the date the first Guangdong case was detected (19th January) and the 
shutdown of travel from Wuhan (23rd January). An overview of testing and surveillance strategies at 
different stages of the epidemic are illustrated below the time series, on the same timescale. (B) 
Geographic distribution of COVID-19 cases and human population density among the 21 prefecture-
level divisions of Guangdong Province. See also Figure S1. 
 
Figure 2: (A) Plot of SARS-CoV-2 genome coverage against RT-PCR Ct value for the 53 genome 
sequences reported here. Each sequence is coloured by sequencing approach: blue = BGI 
metagenomic sequencing, orange = multiplex PCR nanopore sequencing, green = Illumina 
metagenomic sequencing. (B) RT-PCR Ct values for different sample types. (C)  RT-PCR Ct values 
IRUVDPSOHVIURPSDWLHQWVZLWKGLIIHUHQWGLVHDVHVHYHULW\WKHµPLOG¶FDWHJRU\LQFOXGHVDV\PSWRPDWLF
cases. (D) Genome coverage map for the 53 genomes reported here, ordered by % genome coverage. 
Single nucleotide polymorphisms (with respect to the reference genome MN908947.3) are coloured in 
red. Each genome is coloured according to the sequencing approach used. (E) Genomic structure of 
SARS-CoV-2 and the genomic location and frequency of single nucleotide polymorphisms (with 
respect to the reference genome MN908947.3) among our 53 sequences. These mutations correspond 
to the red lines in panel D. See also Figure S2, Supplemental Data File, and Table S1.1. 
Figure 3: (A) Estimated maximum likelihood phylogeny of SARS-CoV-2 sequences from 
Guangdong (red circles) and genomes from other countries and provinces (not circled). The axis is in 
units of nucleotide changes from the inferred root sequence. A phylogenetic bootstrap analysis was 
not performed due to the low number of phylogenetically informative sites and the number of missing 
bases (N) in the alignment. The position of clusters A-E discussed in main text are highlighted with 
red boxes and labelled. (B) Visualisation of the corresponding time-scaled maximum clade credibility 
tree. Sequences from Guangdong and their terminal branches are in red and those from other locations 
in grey. The clusters (A-E) discussed in main text are highlighted with boxes and labelled. All nodes 
with posterior probabilities <0.5 have been collapsed into polytomies and their range of divergence 
dates are illustrated as shaded grey expanses. See also Figure S3-S5. 
Figure 4: Molecular clock analysis of the five phylogenetic clusters of Guangdong sequences 
that were supported with posterior probabilities >80% in Bayesian phylogenetic analysis (A) 
Daily number of local and imported COVID-19 cases in Guangdong province. The first reported case 
in Guangdong (Jan 19) and the shutdown of travel from Wuhan (Jan 23) are indicated by dashed lines. 
(B) Posterior distributions of the tMRCAs of the five phylogenetic clusters (A-E) from the molecular 
clock analysis (Figure 3B). Distributions are truncated at the upper and lower limits of the 95% HPD 
intervals; the vertical red lines indicate median estimates. Blue shading and horizontal red lines 
indicate the sampling period over which genomes in each cluster were collected. Dots indicate the 
collection dates of genomes, coloured by sampling location (red = Guangdong, grey = other). See also 
Table S1.2. 
Supplementary Figure Legends 
Figure S1: Time series of reported cases and sample collection dates. Related to Figure 1. 
(A) Time series of the 1388 laboratory-confirmed COVID-19 cases in Guangdong until 19th March, 
by date of onset of illness. Cases are classified according to their likely exposure histories (see inset). 
The solid line indicates the cumulative number of cases and the dashed lines indicate the date the first 
case was detected in Guangdong (19th January) and the shutdown of travel from Wuhan (23rd 
January). (B) Time series of the 53 SARS-CoV-2 genomes we report, by collection date. Genomes are 
FODVVLILHGDFFRUGLQJWRSDWLHQWV¶OLNHO\H[SRVXUHKLVWRU\7KHFROOHFWLRQGDWHVRISUHYLRXsly released 
genomes sampled from patients in Guangdong are also shown. 
Figure S2: Plots of SARS-CoV-2 genome coverage against RT-PCR Ct value (A) and the 
number of mapped reads (B) for 104 sequencing runs performed on 79 clinical samples. Related 
to Figure 2. Each sequence is coloured by sequencing approach: blue = multiplex PCR nanopore 
sequencing, green = BGI metagenomic sequencing, orange = Illumina metagenomic sequencing. 
Open circles indicate sequences that were not reported here or used in phylogenetic analyses, either 
because of insufficient coverage, or because a higher-quality sequence existed for the same patient. 
Figure S3: Root-to-tip genetic distance for 250 sequences in the maximum likelihood tree 
plotted against collection date. Related to Figure 3. 
The Pearson correlation coefficient between root-to-tip distance and collection date is displayed in the 
top-right corner (r = 0.592). Sequences are coloured by sampling location (Guangdong = red, other 
location = gray).  
Figure S4: Details of the clusters (A-E) of Guangdong genome sequences. Related to Figure 3. 
Extracts from the maximum-likelihood phylogeny are shown on the left and extracts from the 
maximum clade credibility (MCC) tree are shown on the right. Tip labels show GISAID accession 
number; those in red are from Guangdong and those in black are from other locations. Node bars on 
the MCC extracts indicate the 95% HPD interval of node ages. Nodes with posterior probability >0.8 
are labelled with a number and grey circle. 
Figure S5: Screenshots of the online tree visualisation tool. Related to Figure 3. 
The top image shows the 5 clusters A-E highlighted. The bottom image shows the genomes from 
Guangdong highlighted. 
Supplemental Data File: Genome Summaries and Coverage Maps (related to Figure 2) 
Data S1.1: Detailed summary of sequencing information and case data for the 53 genomes reported 
here.  
Data S1.2: Genome coverage map for genomes reported here as well as 49 previously reported 




Further information and requests for resources and reagents should be directed to and will be fulfilled 
by the Lead Contact, Oliver G Pybus (oliver.pybus@zoo.ox.ac.uk). 
Materials Availability  
This study did not generate new unique reagents. 
Data and code availability 
The new sequences have been deposited in GISAID with accession IDs EPI_ISL_413850±413902. 
Code for all figures, tree files, BEAST XML file, BEAST log file, and raw data for Figures 1-4 are 
available at https://github.com/laduplessis/SARS-CoV-2_Guangdong_genomic_epidemiology.  A live 
version of Figure 3B can be found at https://laduplessis.github.io/SARS-CoV-
2_Guangdong_genomic_epidemiology/.  
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
Ethics 
This study was approved by ethics committee of the Center for Disease Control and Prevention of 
Guangdong Province. Written consent was obtained from patients or their guardian(s) when samples 
were collected. Patients were informed about the surveillance before providing written consent, and 
data directly related to disease control were collected and anonymized for analysis. 
Sample collection, clinical surveillance and epidemiological data 
After reports of hospitalized cases with undiagnosed, severe pneumonia on December 30th 2019, 
enhanced surveillance was initiated in Guangdong Province to detect suspected infections, especially 
among cases with recent travel history to Hubei or other epidemic regions over the last 14 days. 
Suspected COVID-19 cases were screened by 31 designated hospitals, local CDCs in 21 prefecture 
cities, and 6 third-party detection institutions with commercial real-time reverse transcription PCR 
(RT-PCR) kits (see below for further details). A subset of positive samples was sent to Guangdong 
Provincial CDC for verification and further sequencing (see below for further details). Imported 
infections were defined when confirmed cases had travel history from Hubei or other epidemic 
regions and did not have close contact with local positive cases in 14 days preceding illness onset. 
The severity of the disease was classified into mild, moderate, severe, or critical (see below for further 
details). Further details of clinical case definitions are provided in Methods. Demographic 
information, date of illness onset, and clinical outcomes of sequenced cases were collected from 
medical records. The exposure history for each case was obtained through an interview. Information 
regarding the demographic and geographic distribution of SARS-CoV-2 cases can be found at the 
website of Health Commission of Guangdong Province (http://wsjkw.gd.gov.cn/xxgzbdfk/yqtb/). 
Further details of surveillance of COVID-19 in Guangdong, China 
The surveillance scheme in Guangdong included 3 main components: 
a. Twenty-one prefecture CDCs and 31 designated hospitals. These are responsible for the
suspected cases diagnoses launched on 30th December 2019. A suspected case was defined if
he/she met one of the following criteria: (i) epidemic history and (ii) fever or respiratory
symptoms (see below for further details). Epidemic history included: (i) a history of travel to
Wuhan or a person who lived in Wuhan or another region where sustained local transmission
existed in the 14 days prior to symptom onset; (ii) contact with a patient with
fever/respiratory symptoms from Wuhan or another region where sustained local transmission
existed in the 14 days prior to symptom onset; (iii) originated from a cluster of COVID-19
cases or is epidemiologically linked to other COVID-19 cases. As of 15th March, 1152 cases
were identified through local CDCs and hospitals.
b. Six third-party detection institutions. More intense surveillance was initiated on 30th January
2020 in response to the Spring Festival period. This included monitoring (i) all healthy
travelers returning from Hubei or other regions with high epidemic activity, (ii) their close
contacts, and (iii) all hospitalized patients in clinics, including those without fever or
respiratory symptoms, regardless of their exposure history. Approximately 1.35 million
samples were screened by six third-party institutions between 30th January and 15th March
2020 and 199 SARS-CoV-2 positive cases were identified from travelers from Hubei without
clinical symptoms (76 in 316,214 or 0.02%), fever clinics (99 in 475,949 or 0.02%), non-
fever clinics (3 in 447,702) and their close contacts (14 in 70,509 or 0.02%).
c. Airport enhanced surveillance. Surveillance commenced at Guangdong airports on 9th March.
As of 15th, 3 positive cases were identified from 7,909 diagnoses in Guangzhou Baiyun
Airport and a total of 92 imported COVID-19 cases were confirmed as of 26th March.
Further details of sequence sample collection 
We collected 58 samples for sequencing from 44 patients (some patients were sampled more than 
RQFHLQIRXUVHQWLQHOKRVSLWDOVLQ*XDQJ]KRX6KHQ]KHQDQG)RVKDQ*XDQJ]KRX(LJKWK3HRSOH¶V
Hospital, 9 samples from 9 patients, collected on 30th January 2020; Guangdong Second Provincial 
General Hospital, 33 samples from 19 patients, collected between 31st January and 9th January 2020; 
7KH7KLUG3HRSOH¶V+RVSLWDORI6KHQ]KHQVDPSOHVIURPSDWLHQWVFollected on 5th February 
)RVKDQ)LUVW3HRSOH¶V+RVSLWDOVDPSOHVIURPSDWLHQWVFROOHFWHGEHWZHHQth February and 
12th February 2020). These cities recorded the highest number of COVID-19 cases (Figure 1B). We 
collected a further 21 samples from 18 patients from a screening project of hospitalized COVID-19 
cases in Guangdong, which was launched on 28th February. We therefore attempted sequencing on 79 
samples from 62 patients (Table S1.1). Because this study focuses on epidemiological questions, we 
retained only one sequence per patient (the highest quality sequence) and we retained only genomes 
with >50% coverage (our quality threshold). This resulted in a final total of 53 genomes. 
Clinical classification of COVID-19 cases 
Cases were diagnosed and the severity status was categorized as mild, moderate, severe, and critical 
according to the Diagnosis and Treatment Scheme for Covid-19 released by the National Health 
Commission of China (Version 7).  
Mild cases: The clinical symptoms were mild, and there was no sign of pneumonia on imaging. 
Moderate cases: Showing fever and respiratory symptoms with radiological findings of pneumonia. 
Severe cases:  Adult cases meeting any of the following criteria: 
i) Respiratory distress (30ؤ breaths/ min);
ii) 2[\JHQVDWXUDWLRQDWUHVW
iii) Arterial partial pressure of oxygen (PaO2)/ fraction of inspired oxygen (FiO2) أ
300mmHg (l mmHg=0.133kPa). 
In high-altitude areas (at an altitude of over 1,000 meters above the sea level), PaO2/ FiO2 
shall be corrected by the following formula: 
PaO2/ FiO2 x [Atmospheric pressure (mmHg)/760] 
Cases with chest imaging that showed obvious lesion progression within 24-48 hours >50% 
shall be managed as severe cases. 
Child cases meeting any of the following criteria: 
i) TachypnHD55EUHDWKVPLQIRULQIDQWVDJHGEHORZPRQWKV55%30
for infants aged 2-PRQWKV55%30IRUFKLOGUHQDJHG-\HDUVDQG55
BPM for children above 5 years old) independent of fever and crying 
ii 2[\JHQVDWXUDWLRQRQILQJHr pulse oximeter taken at rest
iii) Labored breathing (moaning, nasal fluttering, and infrasternal, supraclavicular and
intercostal retraction), cyanosis, and intermittent apnea 
iv) Lethargy and convulsion
v) Difficulty feeding and signs of dehydration
Critical cases: Cases meeting any of the following criteria: 
i) Respiratory failure and requiring mechanical ventilation
ii) Shock
iii) With other organ failure that requires ICU care
METHOD DETAILS 
Virus amplification and sequencing 
Virus genomes were generated by two different approaches, (i) untargeted metagenomic sequencing 
on the BGI MGISEQ-2000 (n=63) and Illumina NextSeq (n=4) sequencing platforms, and (ii) using 
version 1 of the ARTIC COVID-19 multiplex PCR primers (https://artic.network/ncov-2019), 
followed by nanopore sequencing on an ONT MinION (n=45). Untargeted metagenomic sequencing 
was initially attempted as it is well suited to the characterisation of a previously unknown virus. 
Subsequently, a protocol for sequencing SARS-CoV-2 using multiplex PCR with nanopore 
sequencing was made available, which showed good performance on samples with higher Ct values 
(as described below and in Table S1.3). Thereafter, most clinical samples were sequenced using this 
latter approach. We report only those genomes for which we were able to generate >50% genome 
coverage, and report only one genome per patient. 
For metatranscriptomics, total RNAs were extracted from different types of samples by using 
QIAamp Viral RNA Mini Kit, followed by DNase treatment and purification with TURBO DNase 
and Agencourt RNAClean XP beads. Both the concentration and the quality of all isolated RNA 
samples were measured and checked with the Agilent Bioanalyzer 2100 and Qubit. For Illumina 
sequencing, libraries were prepared using the SMARTer Stranded Total RNA-Seq Kit v2 (according 
WRWKHPDQXIDFWXUHU¶VSURWRFROVWDUWLQJZLWKQJWRWDO51$%ULHIO\SXULILHG51$ZDVILUVWO\
fragmented and converted to cDNA using reverse transcriptase. The ribosome cDNA was depleted by 
using ZapRv2 (mammalian-specific). The remaining cDNA was converted to double stranded DNA 
and subjected to end-repair, A-tailing, and adapter ligation. The constructed libraries were amplified 
using 9-ௗPCR cycles. Sequencing of metatranscriptome libraries was conducted on the Illumina 
NextSeq 550 SE 75 platform. For BGI sequencing, DNA-depleted and purified RNA was used to 
construct the single-stranded circular DNA library with MGIEasy RNA Library preparation reagent 
set following PDQXIDFWXUHU¶VSURWRFRO. Finally, 60fmol of PCR products were Unique Dual Indexed 
(UDI), circularized, and amplified by rolling circle replication (RCR) to generate DNA nanoball 
(DNBs)-based libraries. DNBs preps of clinical samples were sequenced on the MGISEQ-2000 
platform.  
For the multiplex PCR approach, we followed the general method of multiplex PCR as described in 
(https://artic.network/ncov-2019) (Quick et al., 2017). Briefly, the multiplex PCR was performed with 
two pooled primer mixture and the cDNA reverse transcribed with random primers was used as a 
template. After 35 rounds of amplification, the PCR products were collected and quantified, followed 
with end-repairing and barcoding ligation. Around 50 fmol of final library DNA was loaded onto the 
MinION. The nanopore sequencing platform takes less than 24 hours to obtain 10Gb of sequencing 
data, achieving between 0.3±0.6 million reads per sample. The ARTIC bioinformatics pipeline for 
COVID (https://artic.network/ncov-2019) was used to generate consensus sequences and call single 
nucleotide changes relative to the reference sequence. SNP differences were sometimes observed 
when the same sample was sequenced using different sequencing approaches. These differences were 
random and not platform specific and, upon close inspection of the reads, most likely resulted from 
low coverage regions in the metagenomics data. Only the single highest-quality genome was retained 
per patient.  
To test the precision and threshold of the multiplex PCR and nanopore sequencing method, we 
undertook a serial dilution experiment. Viral RNA was extracted from a cell strain of SARS-CoV-2. 
To mimic clinical samples with different viral loads, we diluted this viral RNA with SARS-CoV-2-
negative RNA extracted from nasopharyngeal swab specimens. Viral loads were estimated using RT-
PCR with serial diluted plasmid as a standard. At each dilution level we performed multiplex PCR 
and nanopore sequencing and assembly as per the approach above, except that reads were assembled 
against the consensus genome obtained from the original sample using metagenomic sequencing. As 
expected, relative virus load, % genome coverage, and average read depth decreased at higher 
dilutions. Genome coverage exceeded 75% for all except the final dilution (Table S1.3).  
QUANTIFICATION AND STATISTICAL ANALYSIS 
Virus genome assembly 
Reference-based assembly of the metagenomic raw data was performed as follows. Illumina adaptors 
were removed, and reads were filtered for quality (q30 threshold  and read length >15nt) using 
Cutadapt 1.18 (Martin, 2011).  The mapping of cleaned reads was performed against GenBank 
reference strain MN908947.3 using Bowtie2 (Langmead and Salzberg, 2012). Consensus sequences 
were generated using samtools 1.2 (Li et al., 2009). Sites were called at depth>=3 if they matched the 
reference strain, or depth>=5 if they differed from the reference, otherwise sites were denoted N. 
Ambiguity nucleotide codes were used if (i) the minor variant is observed at >30% frequency and (ii) 
the minor variant is represented by 5 or more reads. Assembly of the nanopore raw data was 
performed using the ARTIC bioinformatic pipeline for COVID-19 with minimap2 (Li, 2018) and 
medaka (https://github.com/nanoporetech/medaka) for consensus sequence generation. For patient 
samples that were sequenced using both metagenomics and nanopore sequencing, we retained only 
the sequence with the highest genome coverage. 
Phylogenetic analysis 
All available SARS-CoV-2 sequences (n=323) on GISAID (gisaid.org) on 13th March 2020 were 
downloaded.  Sequences from GISAID that were error-rich, those which represented multiple 
sequences from the same patient, and those without a date of sampling were removed. Finally, the 
dataset was reduced by only retaining the earliest and most recently sampled sequences from 
epidemiologically linked outbreaks (e.g. the Diamond Princess cruise ship). The resulting dataset of 
250 sequences therefore represents the global diversity of the virus while minimizing the impact of 
sampling bias. Sequences were aligned using MAFFT v7.4 (Katoh and Standley, 2013) and manually 
inspected in Geneious v11.0.3 (https://www.geneious.com). The final alignment length was 29,923 
nucleotides. 
We used both the maximum likelihood (ML) and Bayesian coalescent methods to explore the 
phylogenetic structure of SARS-CoV-2. The ML phylogeny was estimated with PhyML (Guindon et 
al., 2010) using the HKY+᫟4 substitution model (Hasegawa et al., 1985) with gamma-distributed rate 
variation (Yang, 1994). Linear regression of root-to-tip genetic distance against sampling date 
indicated that the SARS-CoV-2 sequences evolve in clock-like manner (r = 0.592) (Figure S3). The 
Bayesian coalescent tree analysis was undertaken with BEAST v1.10.4 (Ayres et al., 2012; Suchard et 
al., 2018), also using the HKY+᫟4 substitution model with gamma-distributed rate variation with an 
exponential population growth tree prior and a strict molecular clock, under a non-informative 
continuous-time Markov chain (CTMC) reference prior (Ferreira & Suchard 2008). Taxon sets were 
defined and used to estimate the posterior probability of monophyly and the posterior distribution of 
the tMRCA of observed phylogenetic clusters A-E (Table S1.2). Two independent chains were run for 
100 million states and parameters and trees were sampled every 10,000 states. Upon completion, 
chains were combined using LogCombiner after removing 10% of states as burn-in and convergence 
was assessed with Tracer (Rambaut et al., 2018). The maximum clade credibility (MCC) tree was 
inferred from the Bayesian posterior tree distribution using TreeAnnotator, and visualised with 
figtreejs-react (https://github.com/jtmccr1/figtreejs-react). Monophyly and tMRCA (time to the most 
recent common ancestor) statistics were calculated for each taxon set from the posterior tree 
distribution.  
Supplementary Table (Related to Figures 2 and 4, STAR Methods, and Data Availability) 
Table S1.1: Sample and sequencing information.  
Table S1.2: Taxon sets assessed for monophyly.  
Table S1.3. Serial dilution experiment to test the precision and threshold of the multiplex PCR 
and nanopore sequencing method for SARS-CoV-2.  
Table S1.4: GISAID Sequence Acknowledgments.  
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SUPPLEMENTAL DATA FILE 
Genome Summaries and Coverage Maps (related to Figure 2) 
Genomic epidemiology of SARS-CoV-2 in Guangdong Province, China 
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Data S1.1: Detailed summary of the 53 genomes reported here.  
The figure shows from left to right: (i) GISAID accessions; (ii) sample codes; (iii) patient codes; (iv) 
prefecture; (v) genome coverage map and locations of SNPs (with respect to the reference genome 
MN908947.3), coloured by sequencing platform, with the frequency of SNPs shown below; (vi) 
genome coverage; (vii) RT-PCR Ct value, coloured by disease severity and (viii) the symptom onset 
(asterisks) and collection dates (see legend for the sample types). Where the date of symptom onset is 
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Data S1.2: Genome coverage map for genomes reported here and 49 previously reported 
genomes from Hubei and Guangdong.  
Single nucleotide polymorphisms (with respect to MN908947.3) are coloured in red. Each of the 53 
genomes reported here is coloured according to sequencing approach. GISAID accession numbers 
and sampling locations (province and prefecture) are displayed on the right. (B) Genomic location and 
frequency of single nucleotide polymorphisms (with respect to the reference genome MN908947.3) 
among the 102 genomes in panel A. 
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